Most patients with bilio-pancreatic malignancy are no candidate for curative resection and will need palliative treatment. Palliation in these patients is focussed on relief symptoms such as obstructive jaundice, duodenal obstruction and pain. It has been suggested that non surgical treatment (stenting) is the optimal palliation for patients with short survival and surgical bypass for those surviving more than 6 months. Unfortunately valid criteria for estimating survival are not available except for metastases. A prognostic score chart to predict survival probabilities for 3,6 and 9 months after diagnosis has been developed. The use of this prognostic score chart may help clinicians to select optimal palliative treatment for individual patients. Surgical biliary drainage can be performed by a simple cholecystoenterostomy; a choledochoduodenostomy or a choledocho / hepaticojejunostomy with Roux-Y jejunal limb reconstruction. The present data available in the literature do not give sufficient guidance to make a well deliberated selection between the different types of bypass surgery but choledochojejunostomy is generally preferred. Gastroentero-stomy is performed routinely during the biliary bypass procedure in our institution because gastric outlet obstruction has been described between 9-21 % of the patients who underwent only a surgical biliary bypass but there is still controversy. Recently it was also suggested that there is an indication to perform palliative resections. No results are available to justify resections as a debulking procedure.
Introduction
Unfortunately almost 85% of the patients with bi-liopancreatic malignancy are at the time of presentation no candidate for curative resection and will need palliative treatment [1, 2, 3] . Palliation of these patients is focussed on the relief of the most common symptoms, being obstructive jaundice, gastric outlet obstruction caused by duodenal obstruction and pain. Currently both surgical and non surgical procedures can provide palliation of these symptoms but there is no consensus about the criteria how to select patients for surgical and non surgical treatment. There is also discussion if there is any indication to perform a palliative resection in these patients [3] . If a bypass procedure is performed which type of bypass should be selected and should a prophylactic gastroenterostomy be performed routinely at the time of the biliary bypass. Is there adequate information about the quality of life after palliative surgery. In this review these different aspects of surgical palliative treatment will be discussed.
Obstructive jaundice
Obstructive jaundice is present in approximately 70%-80% of the patients. If untreated it will result in liver failure in short time and patients will suffer from pruritus, nausea and anorexia [1, 2, 3] . Relief of jaundice causes a dramatic improvement in the patients wellbeing and nutritional status, although it may well be only a short time effect because of progression of the disease. After adequate biliary drainage pruritus will disappear within 48 hours. Biliary drainage can be achieved surgically by a bypass procedure and non operatively by a endo-scopically or percutaneously placed endoprosthesis. The initial success rates of a stent-and bypass procedure in terms of relief of the biliary obstruction varies respectively between 82%-100% and between 75%-100%. Four prospective randomized studies have been published, showing that there is no difference in relief of obstruction [4] [5] [6] [7] . Surgical treatment was initially associated with a higher postoperative morbidity and mortality and a longer hospital stay. Non operative treatment by an endoprosthesis however was leading to recurrent jaundice and cholangitis in up to 40% and gastrointestinal obstruction in up to 17% during follow-up in these series. Only one study described the cost effectiveness of surgical palliation versus endoscopic stenting. Endoscopic stenting reduced costs although stent exchanges were necessary in these patients [8] . From these trials it has been suggested that endo-scopic treatment should be the optimal treatment for patients with a relatively short survival time (3 months) while surgical palliation should be preferred for patients with a relatively longer survival time (more than 6 months).
Unfortunately it is still difficult to predict remaining survival of these patients. Previous studies have identified prognostic risk factors for survival [9, 10, 11] . Only presence of metastases appeared to be an imported risk factor but the effect of other identified factors such as age, sex, weight loss and pain were inconsistent. Not only risk factors for survival but also the functional status of the patient at diagnosis (s.a.Karnofski's index) should be considered as an important In a recent study we developed a prognostic score chart to predict survival probabilities for 3, 6 and 9 months after diagnosis. In this study data from 5 studies (1020 patients) were pooled. Three factors: age, sex, metastases and a center specific effect were incorporated in the chart (table 2) . Using this score chart we could select 44% of the patients with a predicted 6 months survival probability of 24% or less and a cohort of 339 patients (33%) with 6 months survival probability of 69% or more [12] . The use of this prognostic score chart may help clinicians to select optimal palliative treatment for individual patients based on predicted survival probabilities. The mortality after surgical bypass in earlier studies and also in the randomized trials was high and varied between 15-24% [5] [6] [7] 13] . This was probably partly due to patient selection. In a recent study from our center a hospital mortality of 2.5% (30 days mortality 0.8%) was found in a consecutive series of 124 patients who underwent bypass surgery [14] . The surgery related complication rate was 17.5 % and hospital stay 17 days. Other studies showed similar results (table 3) and in selected patients bypass surgery is safe nowadays [15, 16] . There is still controversy about the type of surgery. Should an internal biliary drainage procedure being performed by a simple cholecystoenterostomy; a choledochoduodenostomy or a choledocho / hepaticojejunostomy with Roux-Y jejunal limb reconstruction. It has been shown in a review of surgical bypasses that recurrent jaundice occurred in 20% if the gallbladder was used for the bypass (cholecystoenterostomy) compared with 8% after choledochojejunostomy [13] . This was also confirmed in a small randomized trial comparing cholecystoenterostomy with choledochojejunostomy. The first procedure was associated with a higher failure rate and more postoperative complications [17] . If a cholecystoenterostomy is still considered a cholangiography should be performed to control the patency of the cystic duct. The advantage of cholecystoenterostomy is that it can easily be performed laparoscopically. Choledochoduodenostomy has also been avoided because it can lead to recurrent jaundice during follow up mainly caused by duodenal obstruction by local tumor ingrowth. 
Fill in the observed 6 months mortality rate in your own center of the "reference" group (men 60-70 years old without metastases). If you don't know this mortality rate, you can fill in 0.46 (x 50=23 points), which is the observed 6 months mortality rate of men 60-70 years old without metastases in the Triple-P study Recently however Di Fronzo et al. reported a study of 79 patients with unresectable pancreatic cancer of which 71 (90%) underwent a choledochoduodenostomy [18] . Remarkably none of these patients developed recurrent jaundice during a mean survival of 13 months. Delayed complications occurred in 17% of the patients (bleeding 6% and gastric outlet obstruction in 11%). These patients underwent a gastroenterostomy. In a review of more than 1300 patients the incidence of recurrent jaundice was 6.6% (range 0-7%) [18] . This operation is simpler than performing choledochojejunostomy but there was no difference in hospital stay and complications compared with standard choledochojejunostomy. The difference in survival might due to different patient selection and criteria for entry of this study. The present data available in the literature do not give sufficient evidence to make a well deliberated selection between the different types of bypass surgery.
Duodenal obstruction
Symptoms of nausea and vomiting occur in 30-50% of the patients with bilio-pancreatic cancer but mechanical obstruction, mostly at the level of the duodenum, is only reported in a. small percentage of patients. Tumor progression during the disease however will lead to duodenal obstruction more frequently and gastric outlet obstruction has been described between 9-21% of the patients who underwent only a surgical biliary bypass [13] . Therefore gastroenterostomy is performed routinely during a biliary bypass procedure in our institution [14] . In most series morbidity and mortality did not increase by adding a gastroenterostomy to the procedure. In our study the incidence of late duodenal obstruction was low (7%) comparable with a study from USA [15] . Others prefer to perform a gastroenterostomy depending on symptoms (nausea, vomiting) or evidence of duodenal obstruction by endoscopy or barium studies during surgery [7, 9] . Unfortunately results of a gastroenterostomy in patients who presented with nausea and vomiting as major symptoms were disappointing. The in hospital and/or 30 days mortality was 70% mainly caused by a negative patient selection [19] . Nausea and vomiting is also reported after non surgical palliation, and a number of patients will develop duodenal obstruction during follow up. In a consecutive series of 691 patients who underwent endoscopic palliation in our institution duodenal obstruction occurred in 9% of the patients with pancreatic carcinoma and 23% of the patients with ampullary tumors. The excistence of duodenal obstruction correlated with survival time respectively 5 months and 13.5 months (table 4) [20] . Most of these patients (90%) underwent a gastroenterostomy but this procedure is associated with a high mortality (20%) and a limited survival (4 months) because patients had extensive intra-abdominal disease. 
Pain relief
Many patients have abdominal or back pain as presenting symptoms or will develop these complaints during the disease. In most patients adequate pain management can be performed non surgically by medication or percutaneous celiac nerve blocks [1] [2] [3] . A prospective randomized study in patients who underwent bypass surgery with or without chemical splanchinectomy showed that patients with nerve blockade during initial surgery had less pain during follow up [21] . The celiac plexus block is performed by 20cc alcohol 50% at both sides of the celiac trunk during surgery.
Remarkably patients with pre-existing pain who received an alcohol blockade had a significant improvement in survival.
A new development the laparoscopic transthoracic splanchinectomy will be discussed in another chapter.
Palliative resection
There are no studies in which resection has been performed as a routine procedure for palliative treatment. A palliative resection is generally performed if during exploration of a pancreatic tumor infiltration is encountered after transection of the pancreatic neck often regarded as "a point of no return". Another situation is that the tumor was resected with curative intent but the resection margin was not free of tumor and the resection has to be regarded as a palliative procedure. In two studies palliative resections, mainly for the above mentioned indications, were compared with bypass surgery for patients with local tumor ingrowth but with-out metastases [22, 23] . In our series patients were also matched for tumor size. The lymph node status of patients after bypass surgery was unknown and might be different. The mortality and morbidity was not different in both groups 3% versus 0% and 44% versus 33% respectively for a resection and bypass procedure. These results can not be extrapolated to routine palliative resection as a debulking procedure. It however shows that morbidity and mortality are acceptable even after palliative resection and that a more aggressive approach should be considered for these patients in centers with experience.
Quality of life
Quality of life assessment is particularly important in patients who underwent palliative surgical treatment.These patients have a limited (short) survival time and it has been stated in the past that patients after palliative surgical treatment for pancreatic carcinoma spent a considerable part of the remaining time in hospital or with serious impairments due to the operation. Recently quality of life was assessed Iongtudinally in patients who underwent a bypass procedure and a (palliative) pylorus preserving Whipple procedure [24] . Patients were asked to complete the generic MOS (Medical Outcome Studies) and the gastrointestinal quality of life index (GIQLI) questionnaires before and after surgery [24] [25] [26] . A significant temporary postoperative decrease in physical, gastrointestinal functioning and overall QoL domain was found. Almost all QoL scores returned to preoperative values within 3 months. The last 8 weeks before death a rapid decrease on all QoL-scales was found. These results showed that surgical palliative treatment is not associated with irreversible impairment of QoL or an extremely long recovery.
Conclusions
Surgical palliative treatment in bilio-pancreatic malignancy is generally only indicated in patients with a life expectancy of more than 3 months. Stenting should be preferred for short time survivors. A prognostic score chart may be helpful in the selection of patients. The present data from the literature don't give sufficient evidence to make a selection between choledochoduodenostomy or the choledochojejunostomy but the last procedure is preferred by most authors. There is still controversy if a gastroenterostomy should be performed routinely. A palliative resection may be indicated in selected patients. Surgical palliation can be performed with acceptable morbidity and mortality and is not associated with irreversible impairment of the quality of life.
